A reply to questions raised about FEV1Q and bronchodilator responsiveness
- PMID: 36549704
- PMCID: PMC9849703
- DOI: 10.1183/13993003.02025-2022
A reply to questions raised about FEV1Q and bronchodilator responsiveness
Abstract
The recent ATS/ERS technical standard on pulmonary function test interpretive strategies is based on the available evidence
Conflict of interest statement
Conflict of interest: S. Stanojevic reports consulting fees from Chiesi Pharmaceuticals and Vyaire Medical, outside the submitted work. D.A. Kaminsky reports royalties from UptoDate, Inc. for writing on pulmonary function testing, lecture honoraria from MGC Diagnostics, Inc., outside the submitted work. B.R. Thompson reports grants from National Health Medical Research Council, consulting fees from Chiesi, GSK, Mundipharma and 4D Medical, lecture honoraria from Chiesi and Mundipharma, outside the submitted work. M.R. Miller has nothing to disclose.
Comment on
-
ERS/ATS technical standard on interpretive strategies for routine lung function tests.Eur Respir J. 2022 Jul 13;60(1):2101499. doi: 10.1183/13993003.01499-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34949706 Review.
-
A query on FEV1Q: it may be useful, but is it helpful?Eur Respir J. 2023 Jan 19;61(1):2201646. doi: 10.1183/13993003.01646-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36549707 No abstract available.
-
Improving pulmonary function test interpretation.Eur Respir J. 2023 Jan 19;61(1):2201858. doi: 10.1183/13993003.01858-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36549709 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous